Tenon Medical (NASDAQ: TNON) CTO converts RSUs, sells shares for taxes

Rhea-AI Filing Summary

Tenon Medical director and Chief Technology Officer Richard Ginn reported the vesting and conversion of 126,577 restricted stock units into the same number of common shares on July 31, 2026, from RSUs granted on October 13, 2025. On August 3, 2026, he sold 44,809 common shares at $0.198 per share to pay tax liability related to this RSU vesting.

Insider Trade Summary

Net Buyer: 81,768 shares

Net Buy 3 txns

Insider GINN RICHARD

Role Chief Technology Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F2	44,809	$0.198	$9K
Exercise	Restricted Stock Units F1, F3	126,577	$0.00	$0.00
Exercise	Common Stock F1	126,577	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Common Stock — 167,357 shares (Direct)

Footnotes (3)

1. F1. Represents conversion of 126,577 restricted stock units ('RSUs') granted to the reporting person on October 13, 2025 into 126,577 shares of common stock of the Issuer on July 31, 2026.
2. F2. These shares were sold to pay tax liability associated with the vesting of RSUs.
3. F3. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

Key Figures

RSUs converted: 126,577 units Common shares acquired: 126,577 shares Shares sold for taxes: 44,809 shares +3 more

6 metrics

RSUs converted 126,577 units Restricted stock units converted into common stock on July 31, 2026

Common shares acquired 126,577 shares Common stock received from RSU conversion on July 31, 2026

Shares sold for taxes 44,809 shares Common shares sold on August 3, 2026 to pay RSU-related tax liability

Sale price $0.198 per share Price for 44,809 common shares sold on August 3, 2026

RSU grant date October 13, 2025 Grant date of 126,577 RSUs later converted into common stock

RSU-to-share ratio 1 share per RSU Each restricted stock unit represents a contingent right to receive one share of common stock

Key Terms

Restricted Stock Units, tax liability, derivative security

3 terms

Restricted Stock Units financial

"Represents conversion of 126,577 restricted stock units ('RSUs') granted"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax liability financial

"These shares were sold to pay tax liability associated with the vesting"

derivative security financial

"Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/04/2026 - 04:42 PM Accepted by SEC EDGAR 08/04/2026 - 04:42 PM Learn about SEC filing dates

FAQ

What insider transactions did Tenon Medical (TNON) report for Richard Ginn?

Richard Ginn reported conversion of 126,577 RSUs into the same number of Tenon Medical common shares on July 31, 2026, and a subsequent sale of 44,809 shares at $0.198 per share on August 3, 2026 to pay tax liability from that vesting.

How many RSUs vested for Tenon Medical (TNON) CTO Richard Ginn?

The filing shows that 126,577 restricted stock units granted on October 13, 2025 vested and were converted into 126,577 shares of Tenon Medical common stock on July 31, 2026, with each RSU representing a contingent right to receive one share.

Why were 44,809 Tenon Medical (TNON) shares sold on August 3, 2026?

According to the footnotes, 44,809 common shares were sold on August 3, 2026 at $0.198 per share to pay the tax liability associated with the vesting and conversion of Richard Ginn’s restricted stock units into common stock.

What were the dates of Richard Ginn’s recent Tenon Medical (TNON) equity events?

The RSU grant occurred on October 13, 2025, the 126,577 RSUs converted into common stock on July 31, 2026, and 44,809 of the resulting common shares were sold on August 3, 2026 to satisfy related tax obligations.

Were Richard Ginn’s Tenon Medical (TNON) transactions under a Rule 10b5-1 trading plan?

The Form 4 indicates the Rule 10b5-1 checkbox is not affirmed, and the footnotes describe RSU vesting, conversion, and tax-liability sales only. There is no indication in this report that these transactions were executed under a Rule 10b5-1 trading plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GINN RICHARD

(Last) (First) (Middle)

104 COOPER COURT

(Street)

LOS GATOS CALIFORNIA 95032

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Tenon Medical, Inc. [ TNON ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	07/31/2026		M		126,577	A	$0	212,166	D
Common Stock(2)	08/03/2026		F		44,809	D	$0.198	167,357	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units(1)	(3)	07/31/2026		M			126,577	(1)	(1)	Common Stock	126,577	$0	0	D

Explanation of Responses:

1. Represents conversion of 126,577 restricted stock units ('RSUs') granted to the reporting person on October 13, 2025 into 126,577 shares of common stock of the Issuer on July 31, 2026.

2. These shares were sold to pay tax liability associated with the vesting of RSUs.

3. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.

	/s/ Richard Ginn	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)